COL11A1 and breast carcinoma: More interestingly, among the 4 breast cancer subtypes classified according to the expression of PAM50, the overexpression of COL11A1 in Luminal A, Luminal B, and Basal breast cancers all showed a significant impact on the prognosis of patients.